{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:22:47Z","timestamp":1791469367905,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.jpeds.2015.12.029","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T21:47:30Z","timestamp":1453758450000},"page":"25-30.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Risk of Respiratory Syncytial Virus Infection in Cyanotic Congenital Heart Disease in a Subtropical Area"],"prefix":"10.1016","volume":"171","author":[{"given":"Shuenn-Nan","family":"Chiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Lan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Chi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Tai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Yu","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"San-Kuei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jou-Kou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Hwan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2015.12.029_bib1","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1007\/s10096-011-1529-y","article-title":"Epidemiology of hospitalization for acute bronchiolitis in children: differences between RSV and non-RSV bronchiolitis","volume":"31","author":"Hervas","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jpeds.2015.12.029_bib2","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1067\/mpd.2000.110531","article-title":"Rates of hospitalization for respiratory syncytial virus infection among children in medicaid","volume":"137","author":"Boyce","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2015.12.029_bib3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1651-2227.2002.tb03282.x","article-title":"Population-based rates of severe respiratory syncytial virus infection in children with and without risk factors, and outcome in a tertiary care setting","volume":"91","author":"Eriksson","year":"2002","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jpeds.2015.12.029_bib4","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1067\/S0022-3476(03)00454-2","article-title":"Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease","volume":"143","author":"Feltes","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2015.12.029_bib5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1651-2227.2010.02059.x","article-title":"Meta-analysis of passive immunoprophylaxis in paediatric patients at risk of severe RSV infection","volume":"100","author":"Pons","year":"2011","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jpeds.2015.12.029_bib6","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jpeds.2009.11.062","article-title":"Prevalence of congenital heart disease at live birth in Taiwan","volume":"156","author":"Wu","year":"2010","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2015.12.029_bib7","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1542\/peds.2004-0224","article-title":"Economic analysis of palivizumab in infants with congenital heart disease","volume":"114","author":"Yount","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2015.12.029_bib8","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/01.inf.0000126273.27123.33","article-title":"Driscoll Children's Hospital respiratory syncytial virus database: risk factors, treatment and hospital course in 3308 infants and young children, 1991 to 2002","volume":"23","author":"Purcell","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2015.12.029_bib9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1542\/peds.112.3.548","article-title":"Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: a national survey before palivizumab use","volume":"112","author":"Prais","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2015.12.029_bib10","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jcrc.2011.12.001","article-title":"Respiratory syncytial virus morbidity, premorbid factors, seasonality, and implications for prophylaxis","volume":"27","author":"Hon","year":"2012","journal-title":"J Crit Care"},{"key":"10.1016\/j.jpeds.2015.12.029_bib11","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1185\/03007995.2010.505126","article-title":"Fatality rates in published reports of RSV hospitalizations among high-risk and otherwise healthy children","volume":"26","author":"Welliver","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jpeds.2015.12.029_bib12","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/adc.2003.046714","article-title":"Low incidence of respiratory syncytial virus hospitalisations in haemodynamically significant congenital heart disease","volume":"89","author":"Duppenthaler","year":"2004","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jpeds.2015.12.029_bib13","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/01.inf.0000053882.70365.c9","article-title":"Respiratory syncytial virus epidemics: the ups and downs of a seasonal virus","volume":"22","author":"Stensballe","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.jpeds.2015.12.029_bib14","doi-asserted-by":"crossref","DOI":"10.4172\/2327-5073.1000206","article-title":"Viral specific factors contribute to clinical respiratory syncytial virus disease severity differences in infants","volume":"Jun;4","author":"Thompson","year":"2015","journal-title":"Clin Microbiol"},{"key":"10.1016\/j.jpeds.2015.12.029_bib15","doi-asserted-by":"crossref","first-page":"523.e11","DOI":"10.1016\/j.cjca.2010.12.064","article-title":"Economic evaluation of palivizumab in children with congenital heart disease: a Canadian perspective","volume":"27","author":"Harris","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jpeds.2015.12.029_bib16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00246-009-9577-0","article-title":"Impact of palivizumab on RSV hospitalizations for children with hemodynamically significant congenital heart disease","volume":"31","author":"Chang","year":"2010","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jpeds.2015.12.029_bib17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1542\/peds.2014-1665","article-title":"Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection","volume":"134","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2015.12.029_bib18","doi-asserted-by":"crossref","first-page":"e620","DOI":"10.1542\/peds.2014-1666","article-title":"Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection","volume":"134","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2015.12.029_bib19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jmii.2011.01.025","article-title":"Viral etiology of acute lower respiratory tract infections in hospitalized young\u00a0children in Northern Taiwan","volume":"44","author":"Sung","year":"2011","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jpeds.2015.12.029_bib20","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1542\/peds.2004-1300","article-title":"Annual variation in respiratory syncytial virus season and decisions regarding immunoprophylaxis with palivizumab","volume":"114","author":"Meissner","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2015.12.029_bib21","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1086\/315508","article-title":"Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America","volume":"181","author":"Peret","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jpeds.2015.12.029_bib22","doi-asserted-by":"crossref","first-page":"e100981","DOI":"10.1371\/journal.pone.0100981","article-title":"A novel six consecutive monthly doses of palivizumab prophylaxis protocol for the prevention of respiratory syncytial virus infection in high-risk preterm infants in Taiwan","volume":"9","author":"Chi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jpeds.2015.12.029_bib23","doi-asserted-by":"crossref","first-page":"e110166","DOI":"10.1371\/journal.pone.0110166","article-title":"Prolonged seasonality of respiratory syncytial virus infection among preterm infants in a subtropical climate","volume":"9","author":"Hsu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jpeds.2015.12.029_bib24","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1128\/JCM.29.11.2614-2615.1991","article-title":"Respiratory syncytial virus infection and prevalence of subgroups A and B in Hawaii","volume":"29","author":"Reese","year":"1991","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jpeds.2015.12.029_bib25","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1542\/peds.99.3.e9","article-title":"PICNIC (Pediatric Investigators Collaborative Network on Infections in\u00a0Canada) study of the role of age and respiratory syncytial virus neutralizing antibody on respiratory syncytial virus illness in patients with underlying heart or lung disease","volume":"99","author":"Wang","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2015.12.029_bib26","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1542\/peds.2009-2345","article-title":"From the American Academy of Pediatrics: Policy statements\u2014modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections","volume":"124","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2015.12.029_bib27","unstructured":"Recommendations for palivizumab vaccination. In: The Society of Neonatology Taiwan and Taiwan Society of Pediatric Cardiology, eds. Cardiology. Recommendations for prevention of RSV infection in Taiwan. Taipei, Taiwan: Society of Neonatology Taiwan and Taiwan Society of Pediatric Cardiology; 2015. p. 19-22."},{"key":"10.1016\/j.jpeds.2015.12.029_bib28","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1097\/INF.0b013e3181801d76","article-title":"Nationwide survey of palivizumab for respiratory syncytial virus prevention in Japanese children with congenital heart disease","volume":"27","author":"Saji","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2015.12.029_bib29","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s00246-007-9039-5","article-title":"Palivizumab use in subjects with congenital heart disease: results from the 2000-2004 Palivizumab Outcomes Registry","volume":"29","author":"Cohen","year":"2008","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jpeds.2015.12.029_bib30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2165\/11531860-000000000-00000","article-title":"Cost effectiveness of respiratory syncytial virus prophylaxis: a critical and systematic review","volume":"28","author":"Prescott","year":"2010","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jpeds.2015.12.029_bib31","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/archpediatrics.2010.298","article-title":"Cost-effectiveness of respiratory syncytial virus prophylaxis in various indications","volume":"165","author":"Hampp","year":"2011","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jpeds.2015.12.029_bib32","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3111\/13696990903347172","article-title":"Cost effectiveness of palivizumab in children with congenital heart disease in Germany","volume":"12","author":"Nuijten","year":"2009","journal-title":"J Med Econ"},{"key":"10.1016\/j.jpeds.2015.12.029_bib33","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3111\/13696998.2010.499749","article-title":"The cost effectiveness of palivizumab: a systematic review of the evidence","volume":"13","author":"Smart","year":"2010","journal-title":"J Med Econ"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347615015413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347615015413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T10:46:23Z","timestamp":1600080383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347615015413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":33,"alternative-id":["S0022347615015413"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2015.12.029","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Respiratory Syncytial Virus Infection in Cyanotic Congenital Heart Disease in a Subtropical Area","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2015.12.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2015.11.040","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}